Tag: VIVA 2019
VIVA 2019: Competition in the venous stenting space “will ultimately benefit...
Raghu Kolluri (Columbus, USA) and John Kaufman (Portland, USA) talk to BLearning Venous about the highlights from The VEINS (Venous Endovascular INterventional Strategies) session...
Venous News 13 – January 2020 (US Edition)
In this issue of Venous News:
CAVA trial: CDT does not change post-thrombotic risk for iliofemoral DVT patients
Restless legs study establishes association with reflux...
Venous News 13 – January 2020
In this issue of Venous News:
CAVA trial: CDT does not change post-thrombotic risk for iliofemoral DVT patients
Restless legs study establishes association with reflux...
LUPA study confirms effectiveness of accelerated leg ulcer pathway in an...
“The goal needs to remain on improving healing, but also reduced recurrence in the long term,” said Stephen Black (Guy’s and St Thomas’ Hospital,...
John Kaufman
As course director of The VEINS at VIVA 2019 (2–4 November, Las Vegas, USA), John Kaufman tells Venous News how the field of interventional...
Study establishes association between reflux of lateral subdermic plexus and restless...
Reflux of the lateral subdermic plexus—varicose veins which appear on the outside of the thigh and calf—could be closely related to the symptoms of...
New trial planned to rigorously test catheter-directed thrombolysis for submassive PE...
Clinically relevant outcomes are needed to measure catheter-directed therapy (CDT) against anticoagulation alone to treat submassive pulmonary embolism (PE) patients. Further, CDT’s ability to...
VIVA 2019: Open vein hypothesis has “validity” for DVT patients, but...
Suresh Vedantham (St Louis, USA) talks to BLearning Venous after winning the prestigious VEINS award at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las...
EXTRACT-PE trial of aspiration thrombectomy for acute pulmonary embolism meets efficacy...
It has been found by the EXTRACT-PE trial, a multicentre investigation conducted under an investigational device exemption (IDE) from the US Food and Drug...